Target
Mitogen-activated protein kinase 9
Ligand
BDBM50077953
Substrate
n/a
Meas. Tech.
ChEMBL_216693 (CHEMBL820306)
IC50
300±n/a nM
Citation
 Liverton, NJButcher, JWClaiborne, CFClaremon, DALibby, BENguyen, KTPitzenberger, SMSelnick, HGSmith, GRTebben, AVacca, JPVarga, SLAgarwal, LDancheck, KForsyth, AJFletcher, DSFrantz, BHanlon, WAHarper, CFHofsess, SJKostura, MLin, JLuell, SO'Neill, EAO'Keefe, SJ Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase. J Med Chem 42:2180-90 (1999) [PubMed]  Article 
Target
Name:
Mitogen-activated protein kinase 9
Synonyms:
JNK-55 | JNK2 | JNK2/JNK3 | MAPK9 | MK09_HUMAN | Mitogen-Activated Protein Kinase 9 (JNK2) | Mitogen-activated protein kinase 8/9 | PRKM9 | SAPK1A | Stress-activated protein kinase JNK2 | c-Jun N-terminal kinase 2 | c-Jun N-terminal kinase 2 (JNK2)
Type:
Enzyme
Mol. Mass.:
48131.49
Organism:
Homo sapiens (Human)
Description:
JNK-2 was purchased from Upstate Cell Signaling Solutions (formerly Upstate Biotechnology).
Residue:
424
Sequence:
MSDSKCDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMKKLQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMDWEERSKNGVVKDQPSDAAVSSNATPSQSSSINDISSMSTEQTLASDTDSSLDASTGPLEGCR
  
Inhibitor
Name:
BDBM50077953
Synonyms:
4-(1-methyl-2-(piperidin-4-yl)-4-(3-(trifluoromethyl)phenyl)-1H-imidazol-5-yl)-N-((R)-1-phenylethyl)pyrimidin-2-amine | CHEMBL307435 | {4-[3-Methyl-2-piperidin-4-yl-5-(3-trifluoromethyl-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-yl}-((R)-1-phenyl-ethyl)-amine
Type:
Small organic molecule
Emp. Form.:
C28H29F3N6
Mol. Mass.:
506.5653
SMILES:
C[C@@H](Nc1nccc(n1)-c1c(nc(C2CCNCC2)n1C)-c1cccc(c1)C(F)(F)F)c1ccccc1 |r|
Structure:
Search PDB for entries with ligand similarity: